Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 478 participants.
Also called NCT01175824
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 478 participants
- Sponsor
- Registry
-
NCT01175824
-
- Other papers using this trial's data
- Efficacy and safety of a premixed versus a basal-plus insulin regimen as intensification for type 2 diabetes by timing of the main meal
- Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Argentina, Brazil, China, Egypt, India, South Korea, Spain, Türkiye
- Registry status
- Completed
Technical summary
Registry record NCT01175824. Randomized; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2012-11 (actual). Results posted on 2014-02-24.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Insulin Lispro Low Mixture (LM)
- Intervention (Drug)
- Insulin Glargine
- Intervention (Drug)
- Prandial Insulin Lispro
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01175824- Content hash
6c12641c4e99ae49b7524a7c757e90d2194a7278edcc89c11046cfa97fa8fd9a